BACKGROUND
One of the missions of the Pharmacy Department of the CHUV (Centre Hospitalier Universitaire Vaudois) is to secure the supply of the hospital in pharmaceuticals. Medicines not publicly available must be manufactured by the Pharmacy. This can be done batchwise or through a nominal preparation for a specific patient
OBJECTIVES
Batch manufacturing implies a number of principles and constraints such as planning, delays to be taken into account, number of items per batch, final control by the Quality Control Unit, and storage and supplying by the Pharmaceutical Logistics Unit. Because these are often incompatible with personalized medicine, it was necessary to define criteria allowing the Manufacturing Unit to decide between batchwise and individual preparation.
MATERIALS ANS METHODS
Three pharmacists collaborated to conceive and develop a decision algorithm meeting the above objective. This algorithm was then implemented and is being applied to all preparations manufactured by the Pharmacy Department. The following criteria were subsequently taken into account when conceiving the algorithm: standardized doses, stability, frequency and number of prescriptions, urgency and costs (figure 1): 1. Phenobarbital suspension 10 mg/ml 2. Quetiapine suspension 10 mg/ml 3. Dexamethasone suspension 2 mg/ml
In these examples, we considered that a suspension allows a clear YES reply to the question of standardized doses, even for pediatric suspensions which must meet highly variables posologies. 
RESULTS
The first step was to define a batch-wise preparation versus a nominal preparation. The Table below offers a definition of both types of preparations.
